Sleep, cognition & neuro
Selank
Written by the Elevate Clinical Team
Citations independently verified against PubMed, ClinicalTrials.gov, and FDA sources on . Independent clinical review pending.
A synthetic analog of the immunopeptide tuftsin studied for anxiolytic and stress-response effects.
What it is
Selank is a modified tuftsin fragment developed in Russia, where related compounds have been used clinically. Research examines GABAergic and serotonergic signaling plus BDNF expression, with the stated appeal of anxiolysis without sedation or dependence.
What it's studied for
- Anxiety and stress-response measures in Russian clinical work
- BDNF expression and cognitive performance
- Immune-signaling effects inherited from tuftsin
How it's used in practice
- Usually studied intranasally
- Most of the supporting literature is not in English-language peer review
What you should know before asking about it
- Research use only in the United States; not FDA-approved
- Anxiety warrants proper evaluation, not self-directed neuropeptide use
Frequently asked questions.
- What is Selank?
- Selank is a modified tuftsin fragment developed in Russia, where related compounds have been used clinically. Research examines GABAergic and serotonergic signaling plus BDNF expression, with the stated appeal of anxiolysis without sedation or dependence.
- What is Selank studied for?
- Published and ongoing research looks at anxiety and stress-response measures in Russian clinical work; bDNF expression and cognitive performance; immune-signaling effects inherited from tuftsin. These are areas of study, not promised outcomes.
- Is Selank FDA-approved?
- Selank has not been evaluated by the FDA. Elevate Chicago lists it for education and research reference only — it is not prescribed as medical care and is not intended for human consumption.
- How is Selank typically used?
- Usually studied intranasally Most of the supporting literature is not in English-language peer review Any specific dose, frequency or duration comes from a prescription written for you after labs — never from this page.
- What are the risks and unknowns with Selank?
- Research use only in the United States; not FDA-approved Anxiety warrants proper evaluation, not self-directed neuropeptide use
Sources
- 1.Published literature on Selank— PubMed, U.S. National Library of Medicine
- 2.Compounding and the FDA: questions and answers— U.S. Food & Drug Administration
- 3.Bulk drug substances nominated for use in compounding under section 503A— U.S. Food & Drug Administration
- 4.Test directory and patient service center locator— Quest Diagnostics
About this page
Written by the Elevate Clinical Team
Citations independently verified against PubMed, ClinicalTrials.gov, and FDA sources on . Independent clinical review pending. Educational content only — not medical advice, not a diagnosis, and not an offer to sell any prescription product.
This page is educational reference material. It is not medical advice, not a diagnosis, and not an offer to sell any product. Prescription therapies are dispensed only through licensed, FDA-registered compounding pharmacies after a physician evaluation. Compounds identified as research use only are not FDA-approved, are not prescribed as medical care, and are not intended for human or animal consumption. Availability, formulations and regulatory status change over time.
More in Sleep, cognition & neuro
DSIP
A neuropeptide studied for its effect on slow-wave sleep architecture and stress response.
Semax
An ACTH(4-10) analog studied for attention, memory and neuroprotection.
Dihexa
An angiotensin IV analog studied for synapse formation via hepatocyte growth factor signaling.